Abstract

Withania somnifera is one of the most reputed medicinal plants of Indian systems of medicine synthesizing diverse types of secondary metabolites such as withanolides, alkaloids, withanamides etc. Present study comprises cloning and E. coli over-expression of a tropinone reductase gene (WsTR-I) from W. somnifera, and elucidation of biochemical characteristics and physiological role of tropinone reductase enzyme in tropane alkaloid biosynthesis in aerial tissues of the plant. The recombinant enzyme was demonstrated to catalyze NADPH-dependent tropinone to tropine conversion step in tropane metabolism, through TLC, GC and GC-MS-MS analyses of the reaction product. The functionally active homodimeric ∼60 kDa enzyme catalyzed the reaction in reversible manner at optimum pH 6.7. Catalytic kinetics of the enzyme favoured its forward reaction (tropine formation). Comparative 3-D models of landscape of the enzyme active site contours and tropinone binding site were also developed. Tissue-wide and ontogenic stage-wise assessment of WsTR-I transcript levels revealed constitutive expression of the gene with relatively lower abundance in berries and young leaves. The tissue profiles of WsTR-I expression matched those of tropine levels. The data suggest that, in W. somnifera, aerial tissues as well possess tropane alkaloid biosynthetic competence. In vivo feeding of U-[14C]-sucrose to orphan shoot (twigs) and [14C]-chasing revealed substantial radiolabel incorporation in tropinone and tropine, confirming the de novo synthesizing ability of the aerial tissues. This inherent independent ability heralds a conceptual novelty in the backdrop of classical view that these tissues acquire the alkaloids through transportation from roots rather than synthesis. The TR-I gene expression was found to be up-regulated on exposure to signal molecules (methyl jasmonate and salicylic acid) and on mechanical injury. The enzyme's catalytic and structural properties as well as gene expression profiles are discussed with respect to their physiological overtones.

Highlights

  • Withania somnifera, is one of the most reputed medicinal plants of the Indian systems of medicine and forms essential constituent of .100 herbal and nutraceutical formulations [1]

  • Cloning of W. somnifera TR-I (WsTR-I) and Sequence Analysis A cDNA library of W. somnifera roots was used as template for a degenerate primed PCR amplification of Tropinone reductases (TRs)-I

  • It resulted in a 471 bp fragment with highly significant sequence homology with D. stramonium TR-I. 39 RACE of the fragment resulted in a 368 bp amplicon that shared nucleotide sequence homology with 39 region of D. stramonium TR-I sequence

Read more

Summary

Introduction

Withania somnifera (popularly known as Ashwagandha or Indian ginseng), is one of the most reputed medicinal plants of the Indian systems of medicine and forms essential constituent of .100 herbal and nutraceutical formulations [1]. The usual comparatively lower pharmacological efficacies of pure withanolide(s) than the extracts may imply some complementary or enhancive effect of other phytochemicals possessed by the plant, implying importance of the discipline of identifying and understanding components of the ‘systems phytochemical biology’ in the present ‘omic era of biology’ [2] This together with the reports on identification of metabolites related to tropanes and pseudotropanes (including calystegines, the bioactive signature compounds of several food members of Solanaceae family) in the plant, accentuates importance of investigation of biosynthesis of these overlooked phytochemicals in the herb [2], [30], [31], [32]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call